Treatment with Myo-Inositol Does Not Improve the Clinical Features in All PCOS Phenotypes.

Unfer, Vittorio; Russo, Michele; Aragona, Cesare; Bilotta, Gabriele; Montanino Oliva, Mario; Bizzarri, Mariano

Unfer, Vittorio; Russo, Michele; Aragona, Cesare; Bilotta, Gabriele; Montanino Oliva, Mario; Bizzarri, Mariano.

Afiliación

Unfer V; UniCamillus-Saint Camillus International University of Health Sciences, 00131 Rome, Italy.
Russo M; The Experts Group on Inositol in Basic and Clinical Research (EGOI), 00161 Rome, Italy.
Aragona C; R&D Department, Lo.Li. Pharma, 00156 Rome, Italy.
Bilotta G; The Experts Group on Inositol in Basic and Clinical Research (EGOI), 00161 Rome, Italy.
Montanino Oliva M; Systems Biology Group Lab, 00161 Rome, Italy.
Bizzarri M; Alma Res Fertility Center, 00198 Rome, Italy.

Biomedicines ; 11(6)2023 Jun 19.

Article en En | MEDLINE | ID: mdl-37371854

Palabras clave

PCOS; PCOS phenotypes; Rotterdam criteria; metabolic syndrome; myo-Inositol

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Observational_studies Idioma: En Revista: Biomedicines Año: 2023 Tipo del documento: Article País de afiliación: Italia Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google